# The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

> **NCT01101295** · — · UNKNOWN · sponsor: **Henri Mondor University Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Purpura, Thrombocytopenic, Idiopathic
- Autoimmune Thrombocytopenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01101295
- **Lead sponsor:** Henri Mondor University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2012-04
- **Final completion:** 2017-04
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2012-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101295, "The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01101295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*